Following is a summary of current health news briefs. The company has been struggling to meet strong demand for its incretin products, which include its blockbuster diabetes drug Trulicity and recently launched Mounjaro. Last month, the U.S. Food and Drug Administration added both to its list of drugs facing shortages. The health regulator's new draft guidance applies to packaged foods intended for babies and children under two years of age. Inflation has hurt demand for consumer health products and driven up costs for the healthcare conglomerate.
Continue reading...
